Respiratory Syncytial Virus Infections Pipeline Landscape Discussed by Global Markets Direct in Its New Report Available at MarketPublishers.com29 Nov 2017 • by Natalie Aster
LONDON – Respiratory syncytial virus (RSV) contributes to the infection of the lungs and respiratory passages. RSV generally causes bronchiolitis (inflammation of bronchioles - the smallest air passages in the lungs) and pneumonia in kids aged less than 1 year. The symptoms and signs of RSV infection comprise cough, runny or congested nose, mild headache and sore throat, ear pain and fever. Treatment options encompass appropriate medication and good hygiene practices.
New research report “Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2017” elaborated by Global Markets Direct provides deep insights into RSV infections pipeline universe.
The research presents a brief overview of the therapeutic landscape of RSV infections worldwide. It gives information on the respective therapeutics in the pipeline, alongside an analysis by development stage, MoA, drug target, RoA, and type of molecule. The report covers the apparent pharmacological effect of the drugs, its complete R&D history, various developmental activities, and the latest news and press releases pertaining to pipeline therapeutics for RSV infections. The study provides an all-round discussion of the prominent players engaged in the development of therapeutics for RSV infections, and gives an overview of dormant and discontinued projects. The report tracks the emerging players in the marketplace alongside their portfolios.
Reasons to Buy:
- get access to strategically vital analysis, data, and insights to devise efficient R&D strategies;
- pinpoint emerging participants with potentially robust product portfolio and develop workable counter-strategies to get a competitive edge;
- discover significant and diverse types of pipeline therapeutics for RSV infections;
- categorise potential novel clients or partners in the target demographic group;
- and many more.
Other new in-demand research reports by our partner can be found at Global Markets Direct page.